Call to arrange a consultation
+1 416 777 0888

Actelion Pharmaceuticals Ltd. et al v. Sandoz Canada Inc.

2022
T-1750-22
Pending
New PM(NOC) Regulations

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,731,370 and 2,764,475 (selexipag).

Counsel to: 
Sandoz Canada Inc.
here.
Arrow down